Response to topical epinephrine in chronic open-angle glaucoma.
The epinephrine pressure reduction was determined in 32 patients with elevated intraocular pressure (IOP) and 18 patients with untreated chronic open-angle glaucoma. The prevalence of responders was 53% of those patients with elevated IOP and 56% in those patients with open-angle glaucoma. This lack of difference between the two groups is suggestive of the need for caution before applying epinephrine in clinical practice as a predictive factor of future field loss.
D000704:Analysis of Variance; D004837:Epinephrine / Q000494:pharmacology / Q000627:therapeutic use; D005901:Glaucoma / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D011379:Prognosis; D014794:Visual Fields
D004837:Epinephrine